45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
12,618
Insurances with rates
14
CPT / HCPCS codes
10,654
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J1823 | INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION | $329,498 | $139,378 | $197,699 | $280,073 | 6 |
| J1823 | INEBILIZUMAB-CDON 10 MG/ML INTRAVENOUS SOLUTION | $329,498 | $139,378 | $315 | $230,648 | 22 |
| C9293 | GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION | $296,910 | $125,593 | $178,146 | $252,374 | 6 |
| C9293 | GLUCARPIDASE 1000 UNIT INTRAVENOUS SOLUTION | $296,910 | $125,593 | $180 | $207,837 | 12 |
| J9321 | EPCORITAMAB-BYSP 0.16 MG/ML SUBCUTANEOUS SOLUTION | $285,934 | $120,950 | $171,560 | $243,044 | 6 |
| J9321 | EPCORITAMAB-BYSP 0.16 MG/ML SUBCUTANEOUS SOLUTION | $285,934 | $120,950 | $60,046 | $200,153 | 11 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $188,179 | $79,600 | $112,908 | $159,952 | 6 |
| J1747 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $188,179 | $79,600 | $39,518 | $131,726 | 11 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $163,667 | $69,231 | $98,200 | $139,117 | 6 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $163,667 | $69,231 | $1,546 | $114,567 | 22 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $142,346 | $60,212 | $85,408 | $120,994 | 6 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $142,346 | $60,212 | $39.96 | $99,642 | 22 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $136,980 | $57,943 | $82,188 | $116,433 | 6 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $136,980 | $57,943 | $4,341 | $95,886 | 22 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION | $122,923 | $51,996 | $73,754 | $104,484 | 6 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION | $122,923 | $51,996 | $221 | $86,046 | 22 |
| 0408T | INSERT/REPL PCCM SYS | $113,970 | $48,209 | $74,081 | $74,081 | 1 |
| 0408T | INSERT/REPL PCCM SYS | $113,970 | $48,209 | $0.65 | $79,779 | 21 |
| 33289 | IMPT WIRELESS PULM/ART SENSOR | $110,250 | $46,636 | $71,663 | $71,663 | 1 |
| 33289 | IMPT WIRELESS PULM/ART SENSOR | $110,250 | $46,636 | $0.65 | $77,175 | 22 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $102,229 | $43,243 | $61,337 | $86,895 | 6 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $102,229 | $43,243 | $99.67 | $71,560 | 22 |
| J8499 | NINTEDANIB 150 MG CAPSULE | $91,485 | $38,698 | $54,891 | $77,763 | 6 |
| J8499 | NINTEDANIB 150 MG CAPSULE | $91,485 | $38,698 | $19,212 | $64,040 | 11 |
| 33249 | HC INSERT ICD+LEAD SNGL/DUAL | $89,681 | $37,935 | $58,293 | $58,293 | 1 |
| 33249 | HC INSERT ICD+LEAD SNGL/DUAL | $89,681 | $37,935 | $0.65 | $62,777 | 22 |
| 93653 | HC EP&ABLATE SUPRAVENT ARRHYT | $83,880 | $35,481 | $54,522 | $54,522 | 1 |
| 93653 | HC EP&ABLATE SUPRAVENT ARRHYT | $83,880 | $35,481 | $167 | $58,716 | 21 |
| 93654 | HC EP&ABLATE VENTRIC TACHY | $83,880 | $35,481 | $54,522 | $54,522 | 1 |
| 93654 | HC EP&ABLATE VENTRIC TACHY | $83,880 | $35,481 | $167 | $58,716 | 21 |
| 93656 | HC TX ATRIAL FIB PULM VEIN ISOL | $83,880 | $35,481 | $54,522 | $54,522 | 1 |
| 93656 | HC TX ATRIAL FIB PULM VEIN ISOL | $83,880 | $35,481 | $167 | $58,716 | 21 |
| J9272 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $83,630 | $35,375 | $50,178 | $71,085 | 6 |
| J9272 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $83,630 | $35,375 | $17,562 | $58,541 | 11 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $83,377 | $35,268 | $50,026 | $70,870 | 6 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $83,377 | $35,268 | $80.77 | $58,364 | 22 |
| 36906 | AV-THROMBECT W/STNT PERIPH DYL | $83,126 | $35,162 | $54,032 | $54,032 | 1 |
| 36906 | AV-THROMBECT W/STNT PERIPH DYL | $83,126 | $35,162 | $0.65 | $58,188 | 21 |
| 33276 | INST PHRNC NRV STIM SYS | $81,705 | $34,561 | $53,108 | $53,108 | 1 |
| 33276 | INST PHRNC NRV STIM SYS | $81,705 | $34,561 | $5,079 | $57,194 | 4 |
| 0409T | INSERT/REPL PULSE GEN ONLY | $81,660 | $34,542 | $53,079 | $53,079 | 1 |
| 0409T | INSERT/REPL PULSE GEN ONLY | $81,660 | $34,542 | $0.65 | $57,162 | 21 |
| 0414T | REMO/REPL PCCM GEN ONLY | $81,660 | $34,542 | $53,079 | $53,079 | 1 |
| 0414T | REMO/REPL PCCM GEN ONLY | $81,660 | $34,542 | $0.65 | $57,162 | 21 |
| 33270 | HC INS/REP SUBC DEFIBRILLATOR | $78,718 | $33,298 | $51,167 | $51,167 | 1 |
| 33270 | HC INS/REP SUBC DEFIBRILLATOR | $78,718 | $33,298 | $0.65 | $55,103 | 22 |
| J9022 | ATEZOLIZUMAB 1200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $78,265 | $33,106 | $46,959 | $66,526 | 6 |
| J9022 | ATEZOLIZUMAB 1200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $78,265 | $33,106 | $53.05 | $54,786 | 22 |
| J9144 | DARATUMUMAB 1800 MG-HYALURONIDASE-FIHJ 30000 UNIT/15 ML SUBCUT SOLN | $77,627 | $32,836 | $46,576 | $65,983 | 6 |
| J9144 | DARATUMUMAB 1800 MG-HYALURONIDASE-FIHJ 30000 UNIT/15 ML SUBCUT SOLN | $77,627 | $32,836 | $30.7 | $54,339 | 22 |
Showing top 50 of 12,618 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.